North America Intravascular Ultrasound (IVUS) Devices Market

The North America intravascular ultrasound devices market is expected to reach US$ 370.49 million by 2028 from US$ 220.87 million in 2021; it is estimated to grow at a CAGR of 7.7% during 2021–2028.

The market growth in this region is ascribed to the rising prevalence of coronary disorders and an increase in the geriatric population. However, product recalls restrict the market growth.

Canada and Mexico are considerably modernizing their healthcare facilities and services. As a result, the life expectancy of people in these countries has increased, leading to the growth in their geriatric population base. According to the data by the WHO, in February 2018, the aging population is estimated to rise to 22% by 2050 from 12% in 2015. Furthermore, the US Census Bureau states in a report that the number of people in the US with age 65 and above is anticipated to grow from 46 million in 2016 to more than 98 million by 2060. Their population share would increase from ~15% to ~24% during this period. Moreover, underdeveloped and developing countries would account for ~80% of this growth.

In the 2019 Heart Disease and Stroke Statistical Update by the American Heart Association, Inc. (AHA), the incidence of cardiovascular disease (CVDs) was reported to be 77.2% in males and 78.2% in females of age 60–79. Furthermore, the incidence was reported to be 89.3% in males and 91.8% in females with age 80 and above. Age is a prominent risk factor in the development of CVDs. Heart’s physiological aging, and increased oxidative stress and inflammation are the major factors causing the onset and manifestation of CVDs. Thus, a rise in the elderly population underlines the demand for intravascular ultrasound devices (IVUS).

In North America, the COVID-19 pandemic highly impacted the major countries in the initial stages, i.e., during the first wave. In the US, due to increasing number of infected patients and lethal coronavirus variants, the diagnostic and imaging activities came to halt for an extended period during. This led to delay or cancellation of the overall diagnosis of cardiovascular diseases (CVDs) with IVUS in North America. COVID-19 has a potential economic impact on most sectors including, PCI procedures through intravascular ultrasound. The pandemic has also hindered the schedules of cardiovascular diagnosis and surgeries. In 2020, the Center for Disease Control and Prevention (CDC) reported that the medical care for ~41% of adults in the US was delayed or avoided in the year, including a 12% delay in urgent or emergency care and a 32% delay in routine care. According to the report, avoidance of urgent or emergency care was more prevalent among unpaid caregivers. As a result, more cases of advanced cardiovascular diseases are expected in coming years due to delayed diagnosis. The intravascular ultrasound (IVUS) devices market in the US is expected to witness modest growth driven by an aging population, increase in health risk factors such as poor lifestyle, and the adoption of new technologies due to favorable regulatory changes. However, the overall market expansion will be hindered by a saturated installed base of large imaging systems and the consolidation of hospitals.

North America Intravascular Ultrasound (IVUS) Devices Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report Request Free Sample PDF

North America Intravascular Ultrasound (IVUS) Devices Strategic Insights

Strategic insights for the North America Intravascular Ultrasound (IVUS) Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Intravascular Ultrasound (IVUS) Devices Report Scope

North America Intravascular Ultrasound (IVUS) Devices Regional Insights

The geographic scope of the North America Intravascular Ultrasound (IVUS) Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

NORTH AMERICA INTRAVASCULAR ULTRASOUND (IVUS) DEVICES MARKET SEGMENTATION

By Modality

• Virtual Histology IVUS
• iMap IVUS
• Integrated Backscatter IVUS

By Product

• Equipment
• Accessories
  • Catheters
  • Guidewires
  • Others

By End User

• Hospitals and Clinics
• Diagnostic Centers
• Others

By Country

• US
• Canada
• Mexico

Company Profiles

• Koninklijke Philips N.V
• GE Healthcare
• Siemens AG
• Boston Scientific Corporation
• Infraredx, Inc.
• Terumo Corporation
• Axle International
• Conavi Medical Inc.
• Canon Medical Systems
• Abbott
• ACIST Medical Syste